Skip navigation

Testing New Medicines: humans for sale

15th February 2007

As medical and pharmaceutical advances gather pace, often relying on
human subjects for early testing of potential breakthroughs, is there a
cost in human rights in all this that should no longer be borne? Or is
the testing of such drugs on humans, properly done, a solution to other
human rights problems, such as those rooted in disease, ill-health and
premature death? The terrible harm done to six such patients in London
in the Summer of 2006 was noteworthy more because of where it happened
than the fact that it occurred. The World Medical Association has warned
pharmaceutical companies and research organisations to stop exploiting
poor populations by using them to test drugs which only the rich will be
able to afford. The venerable Declaration of Helsinki, first drawn up in
response to the atrocities of the Second World War, when prisoners of
the Nazis were used for experimentation, has been revised to address the
challenges of today.

This event is free and open to all, with no ticket or pre-registration

Date for the diary: Thursday 8 March, 6.30pm 'Mental Health - a new frontier for
human rights protection?'
See for
details of this and other forthcoming events organised by the Centre for
the Study of Human Rights.

23rd November 2017 | LONDON

The standard of review of national court decisions by investment tribunals

Read more

27th November 2017 | LONDON

40th FA Mann Lecture

Read more

4th December 2017 | LONDON

Harry Weinrebe Annual Lecture: Perspectives on 15 years in Business and Human Rights - and on where we may be going next

Read more

6th December 2017 | LONDON

16th Annual Review of the Arbitration Act

Read more

11th December 2017 | LONDON

Legal consequences of the separation of the Chagos Archipelago from Mauritius (ICJ Advisory Opinion)

Read more